Neutral Evolution: The randomness that shapes our DNA
Darwin famously thought of evolution as a force for creation and improvement. Evolution, in his eyes, was synonymous with natural selection and survival of the fittest – a process that optimizes life to thrive in its environment and produce greater numbers of offspring. A century later, however, the great population geneticist Motoo Kimura challenged this view with his 'neutral theory' of evolution (Kimura, 1968). While the neutral theory was more difficult to understand than Darwin's approach, and hence did not capture the public imagination in the same way, it provided the key insight that helped evolution to make sense in the light of molecular biology.
Unlike Darwin, Kimura knew that 'descent with modification' is caused by the transmission of DNA from parents to offspring. When DNA is copied faithfully, children tend to resemble their parents, but copying mistakes and mutagens occasionally create small changes in the DNA sequence, known as genetic variants. Over millions of years, these mutations provided the raw material for natural selection to make a human out of an ape.
It may be tempting to analyze each genetic difference between humans and chimps and wonder why natural selection might have chosen exactly these mutations to build the human phenotype. But Kimura’s theory suggests that this would be a fool’s errand because the vast majority of mutations have no effect on fitness whatsoever. If most mutations fail to alter the fitness of an offspring who carries them, random chance will dictate whether they survive or die. That is, say we compared a human genome and a chimp genome and discovered millions of differences between them: the neutral theory would predict that most of these differences accumulated by chance and that only a tiny fraction gave some kind of fitness advantage to the ancestors of modern humans.
But how much of the genome does indeed evolve neutrally? Although the neutral theory turned 50 this year, this seemingly basic question is still a topic of hot debate (Rands et al., 2014; Graur, 2017). Even the question of what it means for a mutation to evolve neutrally is more complicated than Kimura could have imagined in 1968. Now, in eLife, Fanny Pouyet, Simon Aeschbacher, Alexandre Thiéry and Laurent Excoffier revisit these questions (Pouyet et al., 2018).
Unlike adaptive mutations, which spread through populations as fast as their fitness advantages can carry them, neutral mutations diffuse at a slow, steady rate that is easy to model mathematically (Fisher, 1930). In theory, it is possible to: i) sample DNA sequences from humans worldwide; ii) count and compare the neutral mutations that can be found on multiple continents, one continent, and one individual; iii) use this information to reconstruct details about human migration across the globe (Gutenkunst et al., 2009). In practice, however, it can be hard to deduce whether a given mutation is evolving neutrally or not. When variation under selection is misclassified as neutral and used to study past migrations and changes in population size, the results can be misleading (Ewing and Jensen, 2016; Schrider et al., 2016).
In an ambitious undertaking, Pouyet et al. – who are based at the University of Bern, the Swiss Institute of Bioinformatics and the University of Zurich – discovered how much of the human genome can really be used for this style of demographic analysis. Their results showed that only 5% of the genome is truly evolving neutrally, with the remaining 95% being affected by some kind of natural selection. Superficially, this might seem like a death knell for the neutral theory, but it is nothing of the kind. To understand why, we have to revisit the question of what it means to evolve neutrally.
A mutation will not evolve neutrally if it provides a direct fitness advantage, but the converse does not apply. A mutation can appear to evolve non-neutrally if it is merely located close to a mutation that affects fitness. In sexual organisms like humans, each child inherits DNA from its parents in big, continuous chunks. Even distant cousins will share large chunks of DNA that were inherited from recent common ancestors. If that part of DNA happens to contain a beneficial mutation, hundreds of nearby mutations might hitchhike along for the ride as the beneficial DNA spreads quickly through a population (Smith and Haigh, 1974; Charlesworth et al., 1993). These hitchhikers confer no fitness advantage but, equally, they do not behave the way we expect neutral mutations to do.
Because of this hitchhiking effect, Pouyet et al. advise that genetic variation does not behave neutrally in those regions of the genome that have the lowest recombination rates. (Recombination is the process that stitches together chromosomes from a father and a mother to create a child’s genome.) In regions with high recombination rates, on the other hand, neutral mutations are quickly separated from nearby mutations that are under selection. This makes hitchhiking less of a concern and neutrality a better model.
However, there is one other, somewhat strange, process that we must take into account: biased gene conversion is a process that causes a large fraction of genetic variation to behave non-neutrally, even in regions with high recombination rates (Galtier et al., 2001). It is a quirk of mammalian biochemistry that biased gene conversion makes it slightly more likely for G–C base pairs to be passed down to offspring than A–T base pairs, even when the latter might enhance fitness. As a result, a mutation from A to C may behave like it is beneficial when it is in fact neutral or slightly deleterious. Pouyet et al. suggest that only mutations from G to C, or from A to T, can be truly considered to be neutrally evolving. Together with the restriction to regions with high recombination rates, this rule narrows down the fraction of the genome that is neutrally evolving to 5%.
This amount may seem paltry compared to Kimura’s assertion that neutrality dominates the genome, but it nevertheless contains hundreds (possibly thousands) of mutations, depending on how many human genomes one is looking at simultaneously. These certifiably neutral mutations should prove to be a great resource for future analyses of human demographic history, as it may no longer be defensible to use the whole human genome to make inferences about human migration. It remains to be seen how much of what we think we know about human history has been thrown off by non-neutral evolutionary forces.
References
-
The effect of deleterious mutations on neutral molecular variationGenetics 134:1289–1303.
-
GC-content evolution in mammalian genomes: the biased gene conversion hypothesisGenetics 159:907–911.
-
An upper limit on the functional fraction of the human genomeGenome Biology and Evolution 9:1880–1885.https://doi.org/10.1093/gbe/evx121
-
The hitch-hiking effect of a favourable geneGenetical Research 23:23–35.https://doi.org/10.1017/S0016672300014634
Article and author information
Author details
Publication history
Copyright
© 2018, Harris
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 7,538
- views
-
- 408
- downloads
-
- 6
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
- Genetics and Genomics
A glaucoma polygenic risk score (PRS) can effectively identify disease risk, but some individuals with high PRS do not develop glaucoma. Factors contributing to this resilience remain unclear. Using 4,658 glaucoma cases and 113,040 controls in a cross-sectional study of the UK Biobank, we investigated whether plasma metabolites enhanced glaucoma prediction and if a metabolomic signature of resilience in high-genetic-risk individuals existed. Logistic regression models incorporating 168 NMR-based metabolites into PRS-based glaucoma assessments were developed, with multiple comparison corrections applied. While metabolites weakly predicted glaucoma (Area Under the Curve = 0.579), they offered marginal prediction improvement in PRS-only-based models (p=0.004). We identified a metabolomic signature associated with resilience in the top glaucoma PRS decile, with elevated glycolysis-related metabolites—lactate (p=8.8E-12), pyruvate (p=1.9E-10), and citrate (p=0.02)—linked to reduced glaucoma prevalence. These metabolites combined significantly modified the PRS-glaucoma relationship (Pinteraction = 0.011). Higher total resilience metabolite levels within the highest PRS quartile corresponded to lower glaucoma prevalence (Odds Ratiohighest vs. lowest total resilience metabolite quartile=0.71, 95% Confidence Interval = 0.64–0.80). As pyruvate is a foundational metabolite linking glycolysis to tricarboxylic acid cycle metabolism and ATP generation, we pursued experimental validation for this putative resilience biomarker in a human-relevant Mus musculus glaucoma model. Dietary pyruvate mitigated elevated intraocular pressure (p=0.002) and optic nerve damage (p<0.0003) in Lmx1bV265D mice. These findings highlight the protective role of pyruvate-related metabolism against glaucoma and suggest potential avenues for therapeutic intervention.
-
- Genetics and Genomics
- Neuroscience
The central complex (CX) plays a key role in many higher-order functions of the insect brain including navigation and activity regulation. Genetic tools for manipulating individual cell types, and knowledge of what neurotransmitters and neuromodulators they express, will be required to gain mechanistic understanding of how these functions are implemented. We generated and characterized split-GAL4 driver lines that express in individual or small subsets of about half of CX cell types. We surveyed neuropeptide and neuropeptide receptor expression in the central brain using fluorescent in situ hybridization. About half of the neuropeptides we examined were expressed in only a few cells, while the rest were expressed in dozens to hundreds of cells. Neuropeptide receptors were expressed more broadly and at lower levels. Using our GAL4 drivers to mark individual cell types, we found that 51 of the 85 CX cell types we examined expressed at least one neuropeptide and 21 expressed multiple neuropeptides. Surprisingly, all co-expressed a small molecule neurotransmitter. Finally, we used our driver lines to identify CX cell types whose activation affects sleep, and identified other central brain cell types that link the circadian clock to the CX. The well-characterized genetic tools and information on neuropeptide and neurotransmitter expression we provide should enhance studies of the CX.